Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · IEX Real-Time Price · USD
140.71
+0.88 (0.63%)
At close: May 3, 2024, 4:00 PM
142.26
+1.55 (1.10%)
After-hours: May 3, 2024, 7:55 PM EDT
Neurocrine Biosciences Analyst Ratings
Total Analysts
22
Consensus Rating
Buy
Price Target
$149.00
Upside
+5.89%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $140 → $150 | Hold | Maintains | $140 → $150 | +6.60% | May 3, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $154 → $164 | Strong Buy | Maintains | $154 → $164 | +16.55% | May 2, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $164 → $170 | Strong Buy | Maintains | $164 → $170 | +20.82% | May 2, 2024 |
| Barclays | Barclays | Buy Maintains $150 → $169 | Buy | Maintains | $150 → $169 | +20.11% | May 2, 2024 |
| BMO Capital | BMO Capital | Hold Maintains $129 → $138 | Hold | Maintains | $129 → $138 | -1.93% | May 2, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $200 → $216 | Buy | Maintains | $200 → $216 | +53.51% | May 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $150 → $160 | Strong Buy | Maintains | $150 → $160 | +13.71% | May 2, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 2, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 1, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $140 → $170 | Hold → Buy | Upgrades | $140 → $170 | +20.82% | Apr 24, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $200 | Buy | Maintains | $200 | +42.14% | Apr 24, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +6.60% | Apr 24, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 23, 2024 |
| Wedbush | Wedbush | Buy Reiterates $147 | Buy | Reiterates | $147 | +4.47% | Apr 17, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $155 | Buy | Reiterates | $155 | +10.16% | Apr 10, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $148 → $158 | Buy | Maintains | $148 → $158 | +12.29% | Mar 20, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $170 → $200 | Buy | Maintains | $170 → $200 | +42.14% | Mar 13, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $154 → $148 | Buy | Maintains | $154 → $148 | +5.18% | Feb 23, 2024 |
| Citigroup | Citigroup | Hold Maintains $141 → $140 | Hold | Maintains | $141 → $140 | -0.50% | Feb 8, 2024 |
| Mizuho | Mizuho | Hold Maintains $116 → $140 | Hold | Maintains | $116 → $140 | -0.50% | Feb 8, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $127 → $140 | Hold | Maintains | $127 → $140 | -0.50% | Feb 8, 2024 |